Overview / Abstract: |
Target Audience This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers. Program Overview This activity provides an overview of recent therapeutic advances for patients with newly diagnosed or relapsed multiple myeloma and the mechanisms by which novel therapies work. Learning Objective Upon completion of this activity, participants should be better able to: Assess how novel therapeutic strategies lead to improved survival in myeloma |
Expiration |
Mar 02, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
The Leukemia & Lymphoma Society |
Keywords / Search Terms |
Relias LLC Relias LLC. FreeCME., Myeloma Free CE CME |